EntryPoint Capital’s LianBio American Depositary Shares LIAN Stock Holding History

EntryPoint Capital’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-46	Closed	-$206	–	1836
2023 Q4	$206	Buy	+46	New	+$158	﹤0.01%	1303

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

EntryPoint Capital's LIAN Position: Q1 2024 in Review

EntryPoint Capital sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 46 shares — an estimated $206 sold.

EntryPoint Capital first reported a position in LIAN in Q4 2023 and held it in 1 quarter. The position peaked at $206 in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

EntryPoint Capital reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
EntryPoint Capital sold 46 LianBio American Depositary Shares shares in Q1 2024, an estimated $206.
EntryPoint Capital first reported a position in LianBio American Depositary Shares in Q4 2023 and held it in 1 quarter.
EntryPoint Capital's LianBio American Depositary Shares position peaked at $206 in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.